These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13198244)

  • 1. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. V. Long-term distribution studies with C14-labeled ATA.
    LINDENBAUM A; SCHUBERT J; WHITE MR
    Arch Biochem Biophys; 1954 Sep; 52(1):143-7. PubMed ID: 13198244
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. IV. Comparative effects of related compounds on survival of Be-poisoned animals and on distribution of Be.
    WHITE MR; SCHUBERT J
    Arch Biochem Biophys; 1954 Sep; 52(1):133-42. PubMed ID: 13198243
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoradiographic study of localization of aurintricarboxylic acid in experimental beryllium poisoning.
    LINDENBAUM A; LISCO H
    Proc Soc Exp Biol Med; 1956 Jun; 92(2):354-7. PubMed ID: 13350345
    [No Abstract]   [Full Text] [Related]  

  • 4. The modification of beryllium-induced tissue damage in mice by therapy with aurintricarboxylic acid.
    LISCO H; WHITE MR
    Br J Exp Pathol; 1955 Feb; 36(1):27-34. PubMed ID: 14351635
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. III. Correlation of molecular structure with reversal of biologic effects of beryllium.
    LINDENBAUM A; WHITE MR; SCHUBERT J
    Arch Biochem Biophys; 1954 Sep; 52(1):110-32. PubMed ID: 13198242
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. I.
    SCHUBERT J; WHITE MR; LINDENBAUM A
    J Biol Chem; 1952 May; 196(1):279-88. PubMed ID: 12980968
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECTIVENESS OF AURIN TRICARBOXYLIC ACID (ATA) AS AN ANTIDOTE FOR BERYLLIUM POISONING.
    KING ME; SHEFNER AM; EHRLICH R
    Ind Med Surg; 1964 Aug; 33():566-9. PubMed ID: 14196998
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection against experimental beryllium poisoning by aurin tricarboxylic acid.
    WHITE MR; FINKEL AJ; SCHUBERT J
    J Pharmacol Exp Ther; 1951 Jun; 102(2):88-93. PubMed ID: 14841591
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mechanism of protection by aurintricarboxylic acid in beryllium poisoning. II. Equilibria involving alkaline phosphatase.
    SCHUBERT J; LINDENBAUM A
    J Biol Chem; 1954 May; 208(1):359-68. PubMed ID: 13174545
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aurintricarboxylic acid on beryllium inhibition of alkaline phosphatase.
    LINDENBAUM A; WHITE MR; SCHUBERT J
    J Biol Chem; 1952 May; 196(1):273-8. PubMed ID: 12980967
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicology of aurin tricarboxylic acid and its antidotal effectiveness against beryllium.
    KING ME
    ASD Tech Rep; 1961 Dec; 61(674):23. PubMed ID: 24546958
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihyaluronidasic action of aurintricarboxylic acid].
    COSTE F; DELBARRE E
    C R Seances Soc Biol Fil; 1956 Sep; 150(5):876-9. PubMed ID: 13374968
    [No Abstract]   [Full Text] [Related]  

  • 13. Beryllium and delayed corneal healing; report of a case.
    FLYNN G; RAIFORD M
    AMA Arch Ophthalmol; 1954 Jan; 51(1):89-90. PubMed ID: 13103890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental granulomas due to substances used in fluorescent lamps].
    FARRIS G
    Minerva Dermatol; 1952 Oct; 27(10):230-8. PubMed ID: 13024871
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathologic anatomy of acute experimental beryllium poisoning.
    SCOTT JK
    Arch Pathol (Chic); 1948 Mar; 45():354-9. PubMed ID: 18878123
    [No Abstract]   [Full Text] [Related]  

  • 16. Salicylates and experimental beryllium poisoning.
    FINKEL AJ; WHITE MR
    Proc Soc Exp Biol Med; 1952 Apr; 79(4):672-3. PubMed ID: 14920531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resonance light scattering of aurintricarboxylic acid].
    Wei YJ; Kang ZM; Qi XJ; Mo LP; Liu CG; Zhou QZ
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Feb; 23(1):115-8. PubMed ID: 12939984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurintricarboxylic acid structure modifications lead to reduction of inhibitory properties against virulence factor YopH and higher cytotoxicity.
    Kuban-Jankowska A; Sahu KK; Gorska M; Niedzialkowski P; Tuszynski JA; Ossowski T; Wozniak M
    World J Microbiol Biotechnol; 2016 Oct; 32(10):163. PubMed ID: 27562597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beryllium poisoning in industry].
    BASTENIER H
    Brux Med; 1949 Mar; 29(10):507-16. PubMed ID: 18112420
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical control of beryllium poisoning.
    TABERSHAW IR; DUSTAN C; GOLDWATER LJ
    J Ind Hyg Toxicol; 1949 Jul; 31(4):227-33. PubMed ID: 18153387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.